If you have Pfizer or Moderna, the FDA indicates monitoring these delayed side effects
"Consult a doctor immediately if you have one of the following symptoms," they say.
Since the end of the 2020s, public health experts and health professionals warn people in the United States.Side effects of common Covid vaccine. In this way, once they have been deployed widely, none of us would be alarmed to experience fever, headaches, fatigue, pain or redness on the site of Injection, etc. But some side effects have emerged since then, this has generated more concerns. In mid-April, for example, the use of Johnson & Johnson vaccine has been temporarily suspended in the middle ofReports of rare blood clots, some of whom were fatal. After the disease control and prevention control centers (CDC) and the Food and Drug Administration of the United States (FDA) determined that the benefits of Johnson & Johnson vaccine rejected the risks, the FDAAdding a warning to this vaccine on the potential of coagulation complications. Now, the other two other approved vaccines for emergency use in the United States, Pfizer and Moderna have had new warnings, the courtesy of the FDA. If you have either of these vaccines, the FDA now says three delayed side effects you should look for.
On June 25, the FDA added new warnings for the vaccine supplier and beneficiaries to their fact sheets on Pfizer and Moderna on rare cases of cardiac inflammation called myocarditis (inflammation of heart muscle) and pericarditis (inflammation of The lining outside the heart). The Agency added the warnings only two days after the CCC (ACIP) Vaccination Practices Advisory Committee met and confirmed the "probable association" betweenMyocarditis and pericarditis And the Pfizer and Modern vaccines, which both use the mRNA. However, it's rare, treatable and generally soft, they say.
While the new warning of the FDA notes that the possibility of living cardiac inflammation is "very low", they urge the recipients of Pfizer and Moderna to "seek medical attention right away if you have any of the following symptoms ":
- Chest pain
- Shortness of breath
- Feelings of having a fast, floating or flying heart
The new warning of the FDA, which is the same on the fact sheets for bothPfizer recipients andRecipients of Moderna, says that the symptoms of myocarditis and pericarditis generally do not cultivate immediately, but tend to start "in a few days after receiving the second dose"
The FDA also urged the recipients who have experienced myocarditis or pericarditis in the past to tell their vaccination supplier. For suppliers, the FDA notes that there is a "Increased risks of myocarditis and pericarditis, especially after the second dose. "
According to CDC data, in mid-June, more than 1,200 cases of myocarditis or pericarditis took place in patients who received the anti-Pfizer vaccine or the Moderna vaccine. MostCases have occurred among young men Between 16 and 39 years after their second shot. The estimates of the CDC there will be about 16Case of myocarditis or pericarditis For every million second doses among this demography, which operates at 0.0016 percent, the American Heart Association (AHA) emphasizes.
James de Lemos, MD, Professor of Medicine at the UT Southwestern Medical Center in Dallas, told AHA on the other hand, the chances of a girl who get myocarditis after Covid-19 is "much higher", between 1% and 3%. "It's not something that people, in my opinion, should be afraid. Because the risks are weak and that the benefits of vaccination are overwhelming," said Lemos.
In a statement following the meeting, the ACIP said something similar. "The facts are clear: it's aExtremely rare side effectAnd only an extremely small number of people will experiment after vaccination, "they said." Above all, for young people who do, most cases are light and individuals often recover by themselves or with treatment Minimal. In addition, we know that myocarditis and pericarditis are much more common if you get COVID-19 and that the risks for the heart of a Covid-19 infection can be more serious. "